Request Deal Involvement
Iovance completed the acquisition of Proleukin from Clinigen for £208m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Consilium Strategic Communications
financial advisors
Jefferies & Company
financial advisors
Greenhill & Co
legal advisors
White & Case
or
Principals
bidder
IOVANCE BIOTHERAPEUTICS
vendor
CLINIGEN GROUP PLC
target
PROLEUKIN
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite